20
Participants
Start Date
December 31, 2015
Primary Completion Date
October 31, 2016
Study Completion Date
February 28, 2017
MABp1
This is a sterile injectable liquid formulation of 50 mg/mL MABp1 in a stabilizing isotonic buffer (pH 6.4). Each 10-mL serum vial contains 6 ml of the formulation, and is sealed with a 20-mm grey bromobutyl stopper and flip-off aluminum seal
Placebo
The placebo dosage form is a sterile isotonic formulation buffer at pH 6.2-6.5. Each 10-ml Type I borosilicate glass serum vial contains 6mL of the formulation buffer, and is sealed with a 20-mm Daikyo Flurotec butyl rubber stopper and flip-off aluminum seal.
4th Department of Internal Medicine, ATTIKON University Hospital, Athens
Hellenic Institute for the Study of Sepsis
OTHER
Evangelos J. Giamarellos-Bourboulis, M.D.
OTHER